Evotec has developed considerable in vivo pharmacology expertise in our key therapeutic areas of CNS, metabolic disease and complications, oncology and infectious disease. Our in vivo pharmacology team (> 70 staff), consisting of highly experienced scientists with extensive biopharmaceutical and drug hunting expertise, supports in vivo studies from early target validation through to candidate selection. Furthermore, we have the flexibility to support defined stand-alone studies in addition to in vivo work conducted as part of larger integrated drug discovery programmes. All experimental procedures involving animals are carried out to the highest standards of animal welfare in state-of-the-art facilities and approved according to European Union and national regulations.
Evotec will work with you to identify the most appropriate in vivo pharmacology solution for your drug discovery programme; whether that is an off-the-shelf standard protocol or developing bespoke assays/read-outs for your specific requirements.
For more detailed information, please click on this link or contact us at email@example.com.